← Eichor
Condition: Chordomas Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chordomas

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab and Pemetrexed for Progressive Chordoma
Phase 2 · 1 location(s) · Saint John's Cancer Institute · NCT06794645
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Phase N/A · 3 location(s) · Mayo Clinic · NCT05033288
Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas
Phase N/A · 2 location(s) · Leiden University Medical Center · NCT04832620
Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma
Phase N/A · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06463262
Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease
NA · 28 location(s) · Italian Sarcoma Group · NCT02986516
Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
NA · 21 location(s) · Hospices Civils de Lyon · NCT02838602
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/Phase 2 · 1 location(s) · University of Florida · NCT06625190
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
NA · 1 location(s) · Quironsalud · NCT05861245
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
NA · 1 location(s) · Centre Antoine Lacassagne · NCT06029218
Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
Phase 2 · 1 location(s) · Sarcoma Oncology Research Center, LLC · NCT03886311
Multi-parametric Imaging in Personalized Radiotherapy
Phase N/A · 1 location(s) · CNAO National Center of Oncological Hadrontherapy · NCT05888064
Children and Adults With Chordoma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03910465
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.